Due to unknown effects of this therapy on a fetus, pregnant women are excluded from this research. The male partner should use a condom. Females of child-bearing potential must be willing to utilize one of the more effective birth control methods during the study unless female has had a hysterectomy or tubal ligation TREATMENT: Pregnant women are excluded from this research; the male partner should use a condom; females of child-bearing potential must be willing to utilize one of the more effective birth control methods during the study unless female has had a hysterectomy or tubal ligation Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom Males who are sexually active and not willing to use a condom, and have a partner who is capable of becoming pregnant, if neither has had surgery to become sterilized, and/or who are not willing to use double barrier or whose partner is not using a highly effective method of birth control Sexually active patients must be willing to utilize one of the more effective birth control methods for months after the T cell infusion INCLUSION - TREATMENT: Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom INCLUSION - INFUSION: Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom TREATMENT INCLUSION: Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom Sexually active patients must be willing to utilize one of the more effective birth control methods for months after the T cell infusion; male partner should use a condom Sexually active patients must be willing to utilize one of the more effective birth control methods for months after the ATL infusion; male partner should use a condom ELIGIBILITY CRITERIA AT TIME OF TREATMENT: Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom Pregnant women are excluded from this research; the male partner should use a condom; females of child-bearing potential must be willing to utilize one of the more effective birth control methods during the study unless female has had a hysterectomy or tubal ligation Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom INCLUSION - TREATMENT: Sexually active patients must be willing to utilize one of the more effective birth control methods for months after the cytotoxic T-lymphocyte (CTL) infusion; male partner should use a condom Not pregnant or lactating; sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom ELIGIBILITY CRITERIA- LYMPHODEPLETION/INFUSION OF tvs-CTL: Patients must not be pregnant or lactating; sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom AT THE TIME OF INFUSION: Sexually active subjects must be willing to utilize one of the more effective birth control methods for months after the T cell infusion; the male partner should use a condom TREATMENT: Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom TREATMENT: Pregnant women are excluded from this research; the male partner should use a condom; females of child-bearing potential must be willing to utilize one of the more effective birth control methods during the study unless female has had a hysterectomy or tubal ligation Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom Sexually active patients must be willing to utilize one of the more effective birth control methods for months after the cytotoxic T lymphocyte (CTL) infusion; male partner should use a condom Sexually active patients must be willing to utilize one of the more effective birth control methods for months after the CTL infusion; male partner should use a condom Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use condom Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom AT THE TIME OF INFUSION: Sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for months after the study is concluded; the male partner should use a condom Sexually active patients must be willing to utilize one of the more effective birth control methods for months after the CTL infusion; the male partner should use a condom Patients who are potentially fertile and sexually active must be willing to utilize effective birth control